(Total Views: 765)
Posted On: 09/12/2020 11:24:08 PM
Post# of 153973
“IMMU's Trodelvy has already completed phase 3 and has been approved by the FDA, I think.”
Bottom Line: Leronlimab is a few years behind IMMU’s cancer dug in terms of trials and approval. Comparing CYDY to IMMU at this point, in terms of cancer, is not accurate. Give the drug cancer trials another year or two, and then we might be able to compare.
Bottom Line: Leronlimab is a few years behind IMMU’s cancer dug in terms of trials and approval. Comparing CYDY to IMMU at this point, in terms of cancer, is not accurate. Give the drug cancer trials another year or two, and then we might be able to compare.
(1)
(0)
